Rafael B. M.
- Country
- Spain
- Department
- Cardiology
Research Overview
- Phase Ib Dose-Ranging Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of HS235 Versus Placebo in Combination with Background Therapy in Pulmonary Arterial Hypertension
- Phase 2 Study of REGN13335 Efficacy and Safety in Adults with Pulmonary Arterial Hypertension
- A Phase 3, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Levosimendan in Patients with Pulmonary Hypertension and HFpEF
Data & Insights
Has run more than one trial at 94 of 171 partner sites.
Specializations
Pulmonary Vascular Disorders
This investigator specializes in treating pulmonary arterial hypertension (PAH) and various forms of pulmonary hypertension, conducting research on innovative therapeutic approaches.
- Primary Pulmonary Arterial Hypertension
- Combined Post- and Precapillary Pulmonary Hypertension
- Pulmonary Hypertension with Interstitial Lung Disease
Their work encompasses both established and experimental treatments for pulmonary vascular conditions.
Cardiovascular Complications
The investigator focuses on treating complex cardiovascular conditions, particularly heart failure with preserved ejection fraction (HFpEF) and its relationship to pulmonary vascular disease.
- Heart Failure Management
- Vascular Resistance Assessment
- Exercise Capacity Evaluation
Their research includes long-term safety and efficacy evaluations of cardiovascular treatments.
Therapeutic Innovations
The investigator evaluates novel therapeutic approaches including oral inhalation treatments and specialized medications for pulmonary vascular disorders.
- Targeted Pulmonary Therapies
- Long-term Treatment Outcomes
- Disease-Specific Medication Development
Their work involves assessing treatment efficacy through various clinical parameters and patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.